

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 8.46244298 |
| 2 | triglyceride catabolic process (GO:0019433) | 8.23101006 |
| 3 | white fat cell differentiation (GO:0050872) | 7.93600117 |
| 4 | biotin metabolic process (GO:0006768) | 7.92210717 |
| 5 | valine metabolic process (GO:0006573) | 7.64855776 |
| 6 | acylglycerol catabolic process (GO:0046464) | 7.34585182 |
| 7 | neutral lipid catabolic process (GO:0046461) | 7.34585182 |
| 8 | * brown fat cell differentiation (GO:0050873) | 7.01527862 |
| 9 | fatty acid transmembrane transport (GO:1902001) | 6.65296451 |
| 10 | tachykinin receptor signaling pathway (GO:0007217) | 6.51050079 |
| 11 | triglyceride biosynthetic process (GO:0019432) | 6.17801403 |
| 12 | carnitine shuttle (GO:0006853) | 6.15188395 |
| 13 | acylglycerol biosynthetic process (GO:0046463) | 5.89647834 |
| 14 | neutral lipid biosynthetic process (GO:0046460) | 5.89647834 |
| 15 | regulation of cholesterol storage (GO:0010885) | 5.82202081 |
| 16 | lipid particle organization (GO:0034389) | 5.81351363 |
| 17 | positive regulation of fatty acid oxidation (GO:0046321) | 5.80213609 |
| 18 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.78684287 |
| 19 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.61014610 |
| 20 | glycerolipid catabolic process (GO:0046503) | 5.42567910 |
| 21 | lipid storage (GO:0019915) | 5.33772811 |
| 22 | fatty acid beta-oxidation (GO:0006635) | 5.32944915 |
| 23 | branched-chain amino acid metabolic process (GO:0009081) | 5.15572190 |
| 24 | branched-chain amino acid catabolic process (GO:0009083) | 5.06089486 |
| 25 | behavioral response to nicotine (GO:0035095) | 5.05618021 |
| 26 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.03161544 |
| 27 | thioester biosynthetic process (GO:0035384) | 4.90092772 |
| 28 | acyl-CoA biosynthetic process (GO:0071616) | 4.90092772 |
| 29 | carnitine transmembrane transport (GO:1902603) | 4.87305174 |
| 30 | fatty acid homeostasis (GO:0055089) | 4.84162448 |
| 31 | response to dietary excess (GO:0002021) | 4.83026111 |
| 32 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.78987156 |
| 33 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.78422432 |
| 34 | coenzyme A biosynthetic process (GO:0015937) | 4.78073776 |
| 35 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.76843880 |
| 36 | triglyceride metabolic process (GO:0006641) | 4.72203008 |
| 37 | fatty acid oxidation (GO:0019395) | 4.69008137 |
| 38 | acetyl-CoA metabolic process (GO:0006084) | 4.66109682 |
| 39 | lipid oxidation (GO:0034440) | 4.62529634 |
| 40 | fatty acid catabolic process (GO:0009062) | 4.48729025 |
| 41 | carnitine transport (GO:0015879) | 4.43910715 |
| 42 | amino-acid betaine transport (GO:0015838) | 4.43910715 |
| 43 | acylglycerol metabolic process (GO:0006639) | 4.41768554 |
| 44 | plasma lipoprotein particle clearance (GO:0034381) | 4.41093197 |
| 45 | regulation of fatty acid oxidation (GO:0046320) | 4.38036927 |
| 46 | neutral lipid metabolic process (GO:0006638) | 4.35079617 |
| 47 | negative regulation of protein autophosphorylation (GO:0031953) | 4.32135159 |
| 48 | complement activation, alternative pathway (GO:0006957) | 4.26575682 |
| 49 | negative regulation of lipid storage (GO:0010888) | 4.25589872 |
| 50 | positive regulation of lipid catabolic process (GO:0050996) | 4.23225704 |
| 51 | positive regulation of fatty acid metabolic process (GO:0045923) | 4.21924465 |
| 52 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.18212663 |
| 53 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.17023614 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 4.15510614 |
| 55 | protein heterotrimerization (GO:0070208) | 4.14907808 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 4.14814859 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 4.14814859 |
| 58 | tryptophan catabolic process (GO:0006569) | 4.14814859 |
| 59 | alpha-linolenic acid metabolic process (GO:0036109) | 4.14033818 |
| 60 | positive regulation of digestive system process (GO:0060456) | 4.11275772 |
| 61 | negative regulation of phagocytosis (GO:0050765) | 4.05991127 |
| 62 | pentose-phosphate shunt (GO:0006098) | 4.04746695 |
| 63 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.01057262 |
| 64 | response to pheromone (GO:0019236) | 3.99890899 |
| 65 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.99719910 |
| 66 | detection of light stimulus involved in visual perception (GO:0050908) | 3.99719910 |
| 67 | NADPH regeneration (GO:0006740) | 3.97079169 |
| 68 | kynurenine metabolic process (GO:0070189) | 3.94819706 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 3.93631173 |
| 70 | intracellular lipid transport (GO:0032365) | 3.90534583 |
| 71 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.90386667 |
| 72 | cellular response to lithium ion (GO:0071285) | 3.90342595 |
| 73 | ovulation from ovarian follicle (GO:0001542) | 3.89547137 |
| 74 | platelet dense granule organization (GO:0060155) | 3.87930261 |
| 75 | tricarboxylic acid metabolic process (GO:0072350) | 3.85158986 |
| 76 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.84827636 |
| 77 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.83029108 |
| 78 | positive regulation of lipid storage (GO:0010884) | 3.81090317 |
| 79 | positive regulation of cholesterol efflux (GO:0010875) | 3.76540259 |
| 80 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.74704150 |
| 81 | coenzyme A metabolic process (GO:0015936) | 3.71037428 |
| 82 | negative regulation of macrophage differentiation (GO:0045650) | 3.68151757 |
| 83 | positive regulation of cholesterol transport (GO:0032376) | 3.67848782 |
| 84 | positive regulation of sterol transport (GO:0032373) | 3.67848782 |
| 85 | tryptophan metabolic process (GO:0006568) | 3.66753111 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 3.66458707 |
| 87 | L-fucose catabolic process (GO:0042355) | 3.65879862 |
| 88 | fucose catabolic process (GO:0019317) | 3.65879862 |
| 89 | L-fucose metabolic process (GO:0042354) | 3.65879862 |
| 90 | oxaloacetate metabolic process (GO:0006107) | 3.65649686 |
| 91 | positive regulation of glucose import (GO:0046326) | 3.64375447 |
| 92 | neural tube formation (GO:0001841) | 3.63686861 |
| 93 | positive regulation of glomerulus development (GO:0090193) | 3.61317797 |
| 94 | cornea development in camera-type eye (GO:0061303) | 3.60945360 |
| 95 | DNA deamination (GO:0045006) | 3.59915151 |
| 96 | glycerol metabolic process (GO:0006071) | 3.59580555 |
| 97 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.56829499 |
| 98 | negative regulation of gluconeogenesis (GO:0045721) | 3.51955127 |
| 99 | sulfur amino acid catabolic process (GO:0000098) | 3.51489025 |
| 100 | regulation of lipid storage (GO:0010883) | 3.46992196 |
| 101 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.46897876 |
| 102 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.45359959 |
| 103 | growth hormone receptor signaling pathway (GO:0060396) | 3.42519769 |
| 104 | monocarboxylic acid catabolic process (GO:0072329) | 3.41971061 |
| 105 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.39347552 |
| 106 | regulation of triglyceride metabolic process (GO:0090207) | 3.39150422 |
| 107 | cochlea development (GO:0090102) | 3.39009785 |
| 108 | diacylglycerol metabolic process (GO:0046339) | 3.38548602 |
| 109 | negative regulation of metanephros development (GO:0072217) | 3.37474001 |
| 110 | quaternary ammonium group transport (GO:0015697) | 3.37142871 |
| 111 | long-chain fatty acid transport (GO:0015909) | 3.37074024 |
| 112 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.35479201 |
| 113 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35176863 |
| 114 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.35127418 |
| 115 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34533374 |
| 116 | regulation of macrophage chemotaxis (GO:0010758) | 3.33663449 |
| 117 | triglyceride homeostasis (GO:0070328) | 3.30505972 |
| 118 | acylglycerol homeostasis (GO:0055090) | 3.30505972 |
| 119 | protein K11-linked deubiquitination (GO:0035871) | 3.30177658 |
| 120 | adenosine metabolic process (GO:0046085) | 3.27948623 |
| 121 | L-serine transport (GO:0015825) | 3.27741641 |
| 122 | axoneme assembly (GO:0035082) | 3.25090319 |
| 123 | cellular lipid catabolic process (GO:0044242) | 3.23533655 |
| 124 | respiratory chain complex IV assembly (GO:0008535) | 3.21984150 |
| 125 | behavioral response to ethanol (GO:0048149) | 3.21486924 |
| 126 | retinal cone cell development (GO:0046549) | 3.19969734 |
| 127 | protein-cofactor linkage (GO:0018065) | 3.19338263 |
| 128 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.17798436 |
| 129 | cellular biogenic amine catabolic process (GO:0042402) | 3.00647974 |
| 130 | amine catabolic process (GO:0009310) | 3.00647974 |
| 131 | piRNA metabolic process (GO:0034587) | 2.98013097 |
| 132 | auditory receptor cell stereocilium organization (GO:0060088) | 2.95758212 |
| 133 | indole-containing compound metabolic process (GO:0042430) | 2.94834002 |
| 134 | DNA double-strand break processing (GO:0000729) | 2.93402385 |
| 135 | postsynaptic membrane organization (GO:0001941) | 2.91852436 |
| 136 | cytochrome complex assembly (GO:0017004) | 2.91330696 |
| 137 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.87872782 |
| 138 | replication fork processing (GO:0031297) | 2.86067027 |
| 139 | multicellular organism reproduction (GO:0032504) | 2.85513571 |
| 140 | inner ear receptor cell development (GO:0060119) | 2.84553167 |
| 141 | embryonic epithelial tube formation (GO:0001838) | 2.84189075 |
| 142 | reflex (GO:0060004) | 2.80596962 |
| 143 | sulfation (GO:0051923) | 2.80483641 |
| 144 | protein complex biogenesis (GO:0070271) | 2.78149296 |
| 145 | mannosylation (GO:0097502) | 2.77180703 |
| 146 | inner ear receptor stereocilium organization (GO:0060122) | 2.76362220 |
| 147 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.73630564 |
| 148 | GPI anchor metabolic process (GO:0006505) | 2.73495728 |
| 149 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.71608108 |
| 150 | cilium morphogenesis (GO:0060271) | 2.70947966 |
| 151 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.70448301 |
| 152 | NAD biosynthetic process (GO:0009435) | 2.70088630 |
| 153 | L-methionine salvage (GO:0071267) | 2.69698614 |
| 154 | L-methionine biosynthetic process (GO:0071265) | 2.69698614 |
| 155 | amino acid salvage (GO:0043102) | 2.69698614 |
| 156 | limb bud formation (GO:0060174) | 2.69194325 |
| 157 | sphingoid metabolic process (GO:0046519) | 2.66519497 |
| 158 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.65630373 |
| 159 | NADH dehydrogenase complex assembly (GO:0010257) | 2.65630373 |
| 160 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.65630373 |
| 161 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.65234082 |
| 162 | rhodopsin mediated signaling pathway (GO:0016056) | 2.64968851 |
| 163 | peptidyl-histidine modification (GO:0018202) | 2.64613274 |
| 164 | photoreceptor cell maintenance (GO:0045494) | 2.64528392 |
| 165 | gamma-aminobutyric acid transport (GO:0015812) | 2.64510963 |
| 166 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.64231969 |
| 167 | regulation of meiosis I (GO:0060631) | 2.61423271 |
| 168 | S-adenosylmethionine metabolic process (GO:0046500) | 2.60529315 |
| 169 | epithelial tube formation (GO:0072175) | 2.59674524 |
| 170 | organic cation transport (GO:0015695) | 2.59158547 |
| 171 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.58776663 |
| 172 | benzene-containing compound metabolic process (GO:0042537) | 2.58686341 |
| 173 | photoreceptor cell development (GO:0042461) | 2.57759622 |
| 174 | protein polyglutamylation (GO:0018095) | 2.57508031 |
| 175 | glycosphingolipid biosynthetic process (GO:0006688) | 2.56238029 |
| 176 | regulation of hippo signaling (GO:0035330) | 2.56005385 |
| 177 | primary amino compound metabolic process (GO:1901160) | 2.55066010 |
| 178 | C4-dicarboxylate transport (GO:0015740) | 2.53480650 |
| 179 | righting reflex (GO:0060013) | 2.53169108 |
| 180 | recombinational repair (GO:0000725) | 2.52958532 |
| 181 | sympathetic nervous system development (GO:0048485) | 2.51246020 |
| 182 | double-strand break repair via homologous recombination (GO:0000724) | 2.51109255 |
| 183 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.47982888 |
| 184 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.47532299 |
| 185 | negative regulation of cell cycle arrest (GO:0071157) | 2.45527307 |
| 186 | aromatic amino acid family catabolic process (GO:0009074) | 2.45460673 |
| 187 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.45145417 |
| 188 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.44637639 |
| 189 | regulation of neurotransmitter uptake (GO:0051580) | 2.44520693 |
| 190 | negative regulation of mast cell activation (GO:0033004) | 2.44479770 |
| 191 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.44464130 |
| 192 | phasic smooth muscle contraction (GO:0014821) | 2.43922660 |
| 193 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.43902914 |
| 194 | somite development (GO:0061053) | 2.42862105 |
| 195 | epithelial cilium movement (GO:0003351) | 2.41387513 |
| 196 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.40111091 |
| 197 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.40111091 |
| 198 | visual perception (GO:0007601) | 2.39804508 |
| 199 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.39697954 |
| 200 | low-density lipoprotein particle clearance (GO:0034383) | 10.2075472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.90783424 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.51182630 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.55008137 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.45296308 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.39861372 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.29690928 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19277016 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.17863323 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.92681724 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.91199868 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.82740311 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.81292290 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.76853672 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.70066118 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.50669292 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.49813351 |
| 17 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.26460063 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24453811 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.21973596 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21480881 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.20115209 |
| 22 | P300_19829295_ChIP-Seq_ESCs_Human | 2.19828300 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.19593390 |
| 24 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.18975850 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.12784107 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 2.11594966 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07962272 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.06375240 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.03802467 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03278663 |
| 31 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.4121607 |
| 32 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.91607465 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.90651366 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.89470804 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85159682 |
| 36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.80756892 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.79066345 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.79066345 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76662004 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76241084 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75833524 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.73746653 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73620802 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.70491897 |
| 45 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.68708072 |
| 46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.66893118 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.65973669 |
| 48 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55507907 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55462484 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.54428835 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53418200 |
| 52 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.53214335 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50626984 |
| 54 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50100005 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48951003 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48793053 |
| 57 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.48011056 |
| 58 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.47540483 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47537317 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47263028 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46834879 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46411952 |
| 63 | TCF4_23295773_ChIP-Seq_U87_Human | 1.46309340 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45034801 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44778051 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44682201 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44529639 |
| 68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43896648 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43878784 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43441268 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42467144 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.40693531 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.40194154 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.40085105 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.40085105 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.39696691 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39477902 |
| 78 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.39176159 |
| 79 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.38731812 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38486441 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38432549 |
| 82 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.36441536 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.34299173 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30762030 |
| 85 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.30413247 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30187894 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.29905756 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29635040 |
| 89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27942923 |
| 90 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27541585 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27381940 |
| 92 | NCOR_22424771_ChIP-Seq_293T_Human | 1.27356441 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26445928 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25424147 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25424147 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25215060 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.24701833 |
| 98 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24563378 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.24542296 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23753847 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23640708 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23536995 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22391214 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21208944 |
| 105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20514126 |
| 106 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20154236 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19580651 |
| 108 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18716656 |
| 109 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17450207 |
| 110 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17383827 |
| 111 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16358551 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14705871 |
| 113 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13694855 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13645111 |
| 115 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12981851 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12715932 |
| 117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12678006 |
| 118 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12224539 |
| 119 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11768498 |
| 120 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11768498 |
| 121 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11342182 |
| 122 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11176245 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10569473 |
| 124 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10131353 |
| 125 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09112455 |
| 126 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08499476 |
| 127 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08499476 |
| 128 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08499476 |
| 129 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08211539 |
| 130 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.06878206 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05586514 |
| 132 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03119056 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02173267 |
| 134 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01795596 |
| 135 | NFYB_21822215_ChIP-Seq_K562_Human | 1.00964543 |
| 136 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00742405 |
| 137 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00623866 |
| 138 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00244034 |
| 139 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99799812 |
| 140 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99299626 |
| 141 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99088735 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99061779 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98336362 |
| 144 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98187410 |
| 145 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97698147 |
| 146 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96026154 |
| 147 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93186344 |
| 148 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92423043 |
| 149 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92373827 |
| 150 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92373827 |
| 151 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91125602 |
| 152 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91087914 |
| 153 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89395052 |
| 154 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.87552684 |
| 155 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.87230264 |
| 156 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87086812 |
| 157 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85242355 |
| 158 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84118104 |
| 159 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82986774 |
| 160 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81283021 |
| 161 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80274458 |
| 162 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78232580 |
| 163 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77783591 |
| 164 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76100866 |
| 165 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75817541 |
| 166 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75743047 |
| 167 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.73837047 |
| 168 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.72373456 |
| 169 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.71124450 |
| 170 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70267589 |
| 171 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69306726 |
| 172 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67908359 |
| 173 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67579315 |
| 174 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.66684810 |
| 175 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.66341791 |
| 176 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.63873998 |
| 177 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62841407 |
| 178 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.62430962 |
| 179 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.60381090 |
| 180 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.60045577 |
| 181 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.59973770 |
| 182 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.59427472 |
| 183 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.58081797 |
| 184 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.56277116 |
| 185 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.54643329 |
| 186 | RXR_22108803_ChIP-Seq_LS180_Human | 0.54571401 |
| 187 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.54532000 |
| 188 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.53947005 |
| 189 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.53900432 |
| 190 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.53230628 |
| 191 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.53212204 |
| 192 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.52621790 |
| 193 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.52585157 |
| 194 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52449556 |
| 195 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.52368449 |
| 196 | * P300_27268052_Chip-Seq_Bcells_Human | 0.52025522 |
| 197 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.51876366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.88557071 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.66652499 |
| 3 | MP0004185_abnormal_adipocyte_glucose | 4.77427914 |
| 4 | MP0004130_abnormal_muscle_cell | 4.76439604 |
| 5 | MP0005375_adipose_tissue_phenotype | 3.96599730 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.87397448 |
| 7 | MP0002971_abnormal_brown_adipose | 3.32477343 |
| 8 | MP0003195_calcinosis | 3.25298233 |
| 9 | MP0002876_abnormal_thyroid_physiology | 3.19516191 |
| 10 | MP0009115_abnormal_fat_cell | 3.00615001 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.95501551 |
| 12 | MP0002102_abnormal_ear_morphology | 2.93923094 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.93563694 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.82676900 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.77958118 |
| 16 | MP0002736_abnormal_nociception_after | 2.77853910 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.72166045 |
| 18 | MP0000372_irregular_coat_pigmentation | 2.62706725 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.61871618 |
| 20 | MP0005275_abnormal_skin_tensile | 2.56528783 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.47078418 |
| 22 | * MP0005334_abnormal_fat_pad | 2.43583114 |
| 23 | MP0000003_abnormal_adipose_tissue | 2.41898123 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.38171811 |
| 25 | MP0002970_abnormal_white_adipose | 2.37598937 |
| 26 | MP0003136_yellow_coat_color | 2.29933250 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.10459301 |
| 28 | MP0001661_extended_life_span | 2.08503634 |
| 29 | MP0004885_abnormal_endolymph | 2.06039257 |
| 30 | MP0003186_abnormal_redox_activity | 1.99686227 |
| 31 | MP0005253_abnormal_eye_physiology | 1.97264421 |
| 32 | MP0005535_abnormal_body_temperature | 1.95422666 |
| 33 | MP0004043_abnormal_pH_regulation | 1.94384913 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.89698194 |
| 35 | MP0003880_abnormal_central_pattern | 1.87802202 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.84043629 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.82709967 |
| 38 | * MP0008872_abnormal_physiological_respon | 1.78512815 |
| 39 | MP0003959_abnormal_lean_body | 1.75822866 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.73419866 |
| 41 | MP0003878_abnormal_ear_physiology | 1.73419866 |
| 42 | MP0001486_abnormal_startle_reflex | 1.73335632 |
| 43 | MP0005365_abnormal_bile_salt | 1.71752275 |
| 44 | MP0009745_abnormal_behavioral_response | 1.71337685 |
| 45 | MP0003724_increased_susceptibility_to | 1.70417259 |
| 46 | MP0009697_abnormal_copulation | 1.63762849 |
| 47 | MP0004272_abnormal_basement_membrane | 1.63327092 |
| 48 | MP0004142_abnormal_muscle_tone | 1.62153927 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.61437770 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.60369377 |
| 51 | MP0005448_abnormal_energy_balance | 1.58334555 |
| 52 | MP0000427_abnormal_hair_cycle | 1.56287336 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51852737 |
| 54 | MP0002938_white_spotting | 1.50859550 |
| 55 | MP0002234_abnormal_pharynx_morphology | 1.49542814 |
| 56 | MP0002751_abnormal_autonomic_nervous | 1.48486865 |
| 57 | MP0003690_abnormal_glial_cell | 1.48307278 |
| 58 | MP0000609_abnormal_liver_physiology | 1.47631832 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.46239530 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.45686574 |
| 61 | MP0004742_abnormal_vestibular_system | 1.43508746 |
| 62 | MP0003828_pulmonary_edema | 1.39545353 |
| 63 | MP0001529_abnormal_vocalization | 1.37098140 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.35556120 |
| 65 | * MP0005452_abnormal_adipose_tissue | 1.33967096 |
| 66 | MP0002254_reproductive_system_inflammat | 1.33656871 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 1.31886801 |
| 68 | MP0001881_abnormal_mammary_gland | 1.31793274 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.31526138 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.29999397 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.28147995 |
| 72 | MP0006138_congestive_heart_failure | 1.26691286 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.24882029 |
| 74 | MP0001984_abnormal_olfaction | 1.23808578 |
| 75 | MP0000343_altered_response_to | 1.23694356 |
| 76 | MP0002272_abnormal_nervous_system | 1.21225747 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.20830351 |
| 78 | MP0002095_abnormal_skin_pigmentation | 1.15968536 |
| 79 | MP0003787_abnormal_imprinting | 1.14702857 |
| 80 | MP0003566_abnormal_cell_adhesion | 1.14076384 |
| 81 | MP0005084_abnormal_gallbladder_morpholo | 1.12539298 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 1.10620482 |
| 83 | MP0000026_abnormal_inner_ear | 1.08040411 |
| 84 | MP0001764_abnormal_homeostasis | 1.05717293 |
| 85 | MP0002796_impaired_skin_barrier | 1.04880300 |
| 86 | MP0002638_abnormal_pupillary_reflex | 1.04089548 |
| 87 | MP0008775_abnormal_heart_ventricle | 1.03783054 |
| 88 | MP0002163_abnormal_gland_morphology | 1.03300297 |
| 89 | MP0002332_abnormal_exercise_endurance | 1.02745864 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 1.02599127 |
| 91 | MP0001963_abnormal_hearing_physiology | 1.02560915 |
| 92 | MP0003011_delayed_dark_adaptation | 1.01569757 |
| 93 | MP0004084_abnormal_cardiac_muscle | 1.00868440 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 1.00826589 |
| 95 | MP0005171_absent_coat_pigmentation | 1.00637986 |
| 96 | MP0001727_abnormal_embryo_implantation | 0.98737115 |
| 97 | MP0002653_abnormal_ependyma_morphology | 0.98727492 |
| 98 | MP0002060_abnormal_skin_morphology | 0.98050434 |
| 99 | MP0005164_abnormal_response_to | 0.97155678 |
| 100 | MP0003718_maternal_effect | 0.96714138 |
| 101 | MP0003252_abnormal_bile_duct | 0.95142313 |
| 102 | MP0009046_muscle_twitch | 0.94474807 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93938975 |
| 104 | MP0001324_abnormal_eye_pigmentation | 0.92492593 |
| 105 | MP0004133_heterotaxia | 0.92350956 |
| 106 | MP0001501_abnormal_sleep_pattern | 0.91971688 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.91111059 |
| 108 | MP0003646_muscle_fatigue | 0.90305722 |
| 109 | MP0002572_abnormal_emotion/affect_behav | 0.90004357 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.88795102 |
| 111 | MP0001970_abnormal_pain_threshold | 0.88204380 |
| 112 | MP0000049_abnormal_middle_ear | 0.87827038 |
| 113 | MP0002733_abnormal_thermal_nociception | 0.87484640 |
| 114 | MP0000383_abnormal_hair_follicle | 0.87068742 |
| 115 | MP0003045_fibrosis | 0.87030839 |
| 116 | MP0002557_abnormal_social/conspecific_i | 0.86851767 |
| 117 | MP0002928_abnormal_bile_duct | 0.86807524 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.85866441 |
| 119 | MP0003635_abnormal_synaptic_transmissio | 0.85798409 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.85616816 |
| 121 | MP0000750_abnormal_muscle_regeneration | 0.85432833 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.85208317 |
| 123 | MP0005385_cardiovascular_system_phenoty | 0.84904343 |
| 124 | MP0001544_abnormal_cardiovascular_syste | 0.84904343 |
| 125 | MP0002277_abnormal_respiratory_mucosa | 0.84549267 |
| 126 | MP0005195_abnormal_posterior_eye | 0.83876922 |
| 127 | MP0008995_early_reproductive_senescence | 0.82404812 |
| 128 | MP0002184_abnormal_innervation | 0.82171700 |
| 129 | MP0002067_abnormal_sensory_capabilities | 0.82064446 |
| 130 | MP0005410_abnormal_fertilization | 0.81369353 |
| 131 | MP0005360_urolithiasis | 0.81225271 |
| 132 | MP0003786_premature_aging | 0.80012478 |
| 133 | MP0000647_abnormal_sebaceous_gland | 0.79546902 |
| 134 | MP0003698_abnormal_male_reproductive | 0.78819800 |
| 135 | MP0000516_abnormal_urinary_system | 0.77887805 |
| 136 | MP0005367_renal/urinary_system_phenotyp | 0.77887805 |
| 137 | MP0003943_abnormal_hepatobiliary_system | 0.77541364 |
| 138 | MP0008058_abnormal_DNA_repair | 0.76947134 |
| 139 | MP0004215_abnormal_myocardial_fiber | 0.76898378 |
| 140 | MP0005332_abnormal_amino_acid | 0.76529875 |
| 141 | MP0000538_abnormal_urinary_bladder | 0.76298265 |
| 142 | MP0002006_tumorigenesis | 0.76167146 |
| 143 | MP0000015_abnormal_ear_pigmentation | 0.75877969 |
| 144 | MP0004484_altered_response_of | 0.75874435 |
| 145 | MP0001853_heart_inflammation | 0.75000860 |
| 146 | MP0001756_abnormal_urination | 0.74982038 |
| 147 | MP0003953_abnormal_hormone_level | 0.74598222 |
| 148 | MP0005391_vision/eye_phenotype | 0.74386036 |
| 149 | MP0003948_abnormal_gas_homeostasis | 0.72647779 |
| 150 | MP0005620_abnormal_muscle_contractility | 0.71676193 |
| 151 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71123788 |
| 152 | MP0009763_increased_sensitivity_to | 0.70244190 |
| 153 | MP0005647_abnormal_sex_gland | 0.69264153 |
| 154 | MP0004087_abnormal_muscle_fiber | 0.67512205 |
| 155 | MP0005645_abnormal_hypothalamus_physiol | 0.67020468 |
| 156 | MP0004782_abnormal_surfactant_physiolog | 0.66480292 |
| 157 | MP0005058_abnormal_lysosome_morphology | 0.65224415 |
| 158 | MP0003448_altered_tumor_morphology | 0.64349313 |
| 159 | MP0009643_abnormal_urine_homeostasis | 0.63382078 |
| 160 | MP0002168_other_aberrant_phenotype | 0.61813145 |
| 161 | MP0000858_altered_metastatic_potential | 0.61426813 |
| 162 | MP0005379_endocrine/exocrine_gland_phen | 0.57970366 |
| 163 | MP0009672_abnormal_birth_weight | 0.56814211 |
| 164 | MP0000759_abnormal_skeletal_muscle | 0.56542702 |
| 165 | MP0005076_abnormal_cell_differentiation | 0.55244224 |
| 166 | MP0000598_abnormal_liver_morphology | 0.55081510 |
| 167 | MP0002295_abnormal_pulmonary_circulatio | 0.54798654 |
| 168 | MP0004147_increased_porphyrin_level | 0.54089846 |
| 169 | MP0000249_abnormal_blood_vessel | 0.52933941 |
| 170 | MP0009780_abnormal_chondrocyte_physiolo | 0.52792914 |
| 171 | MP0001545_abnormal_hematopoietic_system | 0.51647008 |
| 172 | MP0005397_hematopoietic_system_phenotyp | 0.51647008 |
| 173 | MP0002909_abnormal_adrenal_gland | 0.51463162 |
| 174 | MP0005376_homeostasis/metabolism_phenot | 0.51167498 |
| 175 | MP0001533_abnormal_skeleton_physiology | 0.50311509 |
| 176 | MP0005330_cardiomyopathy | 0.50015605 |
| 177 | MP0001177_atelectasis | 0.48603529 |
| 178 | MP0005167_abnormal_blood-brain_barrier | 0.48562750 |
| 179 | MP0005266_abnormal_metabolism | 0.48500304 |
| 180 | MP0002972_abnormal_cardiac_muscle | 0.47627154 |
| 181 | MP0008961_abnormal_basal_metabolism | 0.45455265 |
| 182 | MP0000627_abnormal_mammary_gland | 0.43421477 |
| 183 | MP0001879_abnormal_lymphatic_vessel | 0.43049770 |
| 184 | MP0010630_abnormal_cardiac_muscle | 0.43044350 |
| 185 | MP0000751_myopathy | 0.42465598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 9.38133711 |
| 2 | Acanthosis nigricans (HP:0000956) | 7.67949927 |
| 3 | Hyperglycinuria (HP:0003108) | 7.05826209 |
| 4 | Hypertriglyceridemia (HP:0002155) | 6.98650603 |
| 5 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.52078873 |
| 6 | Abnormality of glycine metabolism (HP:0010895) | 5.52078873 |
| 7 | Complement deficiency (HP:0004431) | 5.35956945 |
| 8 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.93748884 |
| 9 | Long foot (HP:0001833) | 4.92955105 |
| 10 | Pancreatic cysts (HP:0001737) | 4.12008211 |
| 11 | Hydroxyprolinuria (HP:0003080) | 4.08029305 |
| 12 | Abnormality of proline metabolism (HP:0010907) | 4.08029305 |
| 13 | Myoglobinuria (HP:0002913) | 3.98116816 |
| 14 | Pigmentary retinal degeneration (HP:0001146) | 3.95278416 |
| 15 | Abnormality of complement system (HP:0005339) | 3.95039879 |
| 16 | Pancreatic fibrosis (HP:0100732) | 3.86548566 |
| 17 | True hermaphroditism (HP:0010459) | 3.83883475 |
| 18 | Growth hormone excess (HP:0000845) | 3.83236618 |
| 19 | Multiple enchondromatosis (HP:0005701) | 3.82496942 |
| 20 | Insulin resistance (HP:0000855) | 3.81784041 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.75795012 |
| 22 | Hyperglycinemia (HP:0002154) | 3.68775495 |
| 23 | Difficulty running (HP:0009046) | 3.67821577 |
| 24 | Attenuation of retinal blood vessels (HP:0007843) | 3.67659351 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.56141776 |
| 26 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.55992337 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.49592694 |
| 28 | Congenital stationary night blindness (HP:0007642) | 3.49590475 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.46433063 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.42024034 |
| 31 | Bone cyst (HP:0012062) | 3.41983026 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41239728 |
| 33 | Abnormality of macular pigmentation (HP:0008002) | 3.40619625 |
| 34 | Thyroid-stimulating hormone excess (HP:0002925) | 3.38581490 |
| 35 | Rhabdomyolysis (HP:0003201) | 3.32463983 |
| 36 | Epidermoid cyst (HP:0200040) | 3.31157102 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 3.27182025 |
| 38 | Subcapsular cataract (HP:0000523) | 3.23796513 |
| 39 | Hyperammonemia (HP:0001987) | 3.22563581 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 3.19166423 |
| 41 | Abnormality of midbrain morphology (HP:0002418) | 3.19166423 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 3.18191095 |
| 43 | Chronic hepatic failure (HP:0100626) | 3.12000872 |
| 44 | Ketosis (HP:0001946) | 3.10130296 |
| 45 | Nausea (HP:0002018) | 3.09389084 |
| 46 | Ketoacidosis (HP:0001993) | 3.08878140 |
| 47 | Pendular nystagmus (HP:0012043) | 3.06128918 |
| 48 | Constricted visual fields (HP:0001133) | 3.03811847 |
| 49 | Large hands (HP:0001176) | 3.02977192 |
| 50 | Myocardial infarction (HP:0001658) | 3.01014493 |
| 51 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.99393386 |
| 52 | Hyperpituitarism (HP:0010514) | 2.93773612 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.93658566 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.93658566 |
| 55 | Increased connective tissue (HP:0009025) | 2.93144554 |
| 56 | Abnormality of the renal cortex (HP:0011035) | 2.92874897 |
| 57 | Chorioretinal atrophy (HP:0000533) | 2.91663378 |
| 58 | Inability to walk (HP:0002540) | 2.89859164 |
| 59 | Decreased central vision (HP:0007663) | 2.89001215 |
| 60 | Increased corneal curvature (HP:0100692) | 2.88776099 |
| 61 | Keratoconus (HP:0000563) | 2.88776099 |
| 62 | Abolished electroretinogram (ERG) (HP:0000550) | 2.88710219 |
| 63 | Nephronophthisis (HP:0000090) | 2.86837314 |
| 64 | Progressive inability to walk (HP:0002505) | 2.85227795 |
| 65 | Hyperthyroidism (HP:0000836) | 2.83202836 |
| 66 | Congenital sensorineural hearing impairment (HP:0008527) | 2.83023885 |
| 67 | Abnormal cartilage morphology (HP:0002763) | 2.81327947 |
| 68 | Type II lissencephaly (HP:0007260) | 2.81298689 |
| 69 | Gaze-evoked nystagmus (HP:0000640) | 2.78918195 |
| 70 | Pancreatitis (HP:0001733) | 2.78235461 |
| 71 | Tetraparesis (HP:0002273) | 2.75329412 |
| 72 | Hypoplasia of the fovea (HP:0007750) | 2.74101566 |
| 73 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.74101566 |
| 74 | Prenatal maternal abnormality (HP:0002686) | 2.68250134 |
| 75 | Facial diplegia (HP:0001349) | 2.66329380 |
| 76 | Absent speech (HP:0001344) | 2.64838532 |
| 77 | Abnormality of the renal medulla (HP:0100957) | 2.63208283 |
| 78 | Hyperventilation (HP:0002883) | 2.63161182 |
| 79 | Cystic liver disease (HP:0006706) | 2.60605881 |
| 80 | Limb hypertonia (HP:0002509) | 2.60394903 |
| 81 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.58410698 |
| 82 | Abnormal hemoglobin (HP:0011902) | 2.57026947 |
| 83 | Accelerated skeletal maturation (HP:0005616) | 2.55500130 |
| 84 | Medial flaring of the eyebrow (HP:0010747) | 2.46870999 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 2.45153810 |
| 86 | Skin nodule (HP:0200036) | 2.44353648 |
| 87 | Xanthomatosis (HP:0000991) | 2.41174215 |
| 88 | Abnormality of the fovea (HP:0000493) | 2.40822912 |
| 89 | Anencephaly (HP:0002323) | 2.40275771 |
| 90 | Chromsome breakage (HP:0040012) | 2.40232237 |
| 91 | Sclerocornea (HP:0000647) | 2.39364555 |
| 92 | Hypercholesterolemia (HP:0003124) | 2.36681446 |
| 93 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.36311974 |
| 94 | Prostate neoplasm (HP:0100787) | 2.35765689 |
| 95 | Lipoatrophy (HP:0100578) | 2.33258401 |
| 96 | Renal cortical cysts (HP:0000803) | 2.33045324 |
| 97 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.32165527 |
| 98 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.31161893 |
| 99 | Neonatal hypoglycemia (HP:0001998) | 2.30742777 |
| 100 | Testicular atrophy (HP:0000029) | 2.27508353 |
| 101 | Clitoromegaly (HP:0000057) | 2.26561378 |
| 102 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.23914958 |
| 103 | Tubular atrophy (HP:0000092) | 2.22086128 |
| 104 | Cerebral aneurysm (HP:0004944) | 2.21405542 |
| 105 | Hyperglycemia (HP:0003074) | 2.18889687 |
| 106 | Hypoproteinemia (HP:0003075) | 2.18866127 |
| 107 | Progressive cerebellar ataxia (HP:0002073) | 2.14926919 |
| 108 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.14889785 |
| 109 | Methylmalonic acidemia (HP:0002912) | 2.12814717 |
| 110 | Ankle contracture (HP:0006466) | 2.10986921 |
| 111 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.09587678 |
| 112 | Spinal rigidity (HP:0003306) | 2.08981141 |
| 113 | Bilateral microphthalmos (HP:0007633) | 2.08842370 |
| 114 | Toxemia of pregnancy (HP:0100603) | 2.07260313 |
| 115 | Prominent supraorbital ridges (HP:0000336) | 2.06721551 |
| 116 | Broad metatarsal (HP:0001783) | 2.06069835 |
| 117 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.05471564 |
| 118 | Occipital encephalocele (HP:0002085) | 2.04741403 |
| 119 | Abnormality of the labia minora (HP:0012880) | 2.04628162 |
| 120 | Polygenic inheritance (HP:0010982) | 2.00208369 |
| 121 | Tubulointerstitial nephritis (HP:0001970) | 1.99936403 |
| 122 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99855102 |
| 123 | Abnormality of alanine metabolism (HP:0010916) | 1.99855102 |
| 124 | Hyperalaninemia (HP:0003348) | 1.99855102 |
| 125 | Postaxial foot polydactyly (HP:0001830) | 1.99510083 |
| 126 | Abnormality of serum amino acid levels (HP:0003112) | 1.99454888 |
| 127 | Abnormal drinking behavior (HP:0030082) | 1.98096978 |
| 128 | Polydipsia (HP:0001959) | 1.98096978 |
| 129 | Small hand (HP:0200055) | 1.97804458 |
| 130 | Clumsiness (HP:0002312) | 1.97476477 |
| 131 | Male pseudohermaphroditism (HP:0000037) | 1.97438991 |
| 132 | Decreased subcutaneous fat (HP:0001002) | 1.95499682 |
| 133 | Hypothermia (HP:0002045) | 1.94947342 |
| 134 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94116254 |
| 135 | Cerebellar dysplasia (HP:0007033) | 1.91553761 |
| 136 | Broad-based gait (HP:0002136) | 1.91251641 |
| 137 | Genital tract atresia (HP:0001827) | 1.90161250 |
| 138 | Polar cataract (HP:0010696) | 1.88928971 |
| 139 | Congenital hepatic fibrosis (HP:0002612) | 1.88519014 |
| 140 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.87974265 |
| 141 | Asplenia (HP:0001746) | 1.87843062 |
| 142 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.87709634 |
| 143 | Acute encephalopathy (HP:0006846) | 1.87152163 |
| 144 | Macular degeneration (HP:0000608) | 1.86734481 |
| 145 | Oligohydramnios (HP:0001562) | 1.86701236 |
| 146 | Decreased circulating renin level (HP:0003351) | 1.86280068 |
| 147 | Optic disc pallor (HP:0000543) | 1.86180025 |
| 148 | Optic nerve hypoplasia (HP:0000609) | 1.85542156 |
| 149 | Acute necrotizing encephalopathy (HP:0006965) | 1.85183132 |
| 150 | Methylmalonic aciduria (HP:0012120) | 1.84577863 |
| 151 | Generalized aminoaciduria (HP:0002909) | 1.84400359 |
| 152 | Mitochondrial inheritance (HP:0001427) | 1.81638794 |
| 153 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.81505457 |
| 154 | Lethargy (HP:0001254) | 1.81334341 |
| 155 | Gait imbalance (HP:0002141) | 1.81223937 |
| 156 | Right ventricular cardiomyopathy (HP:0011663) | 1.80946466 |
| 157 | Focal seizures (HP:0007359) | 1.80115517 |
| 158 | Congenital, generalized hypertrichosis (HP:0004540) | 1.79660517 |
| 159 | Type I transferrin isoform profile (HP:0003642) | 1.79284378 |
| 160 | Thyroiditis (HP:0100646) | 1.79151642 |
| 161 | Lissencephaly (HP:0001339) | 1.79143357 |
| 162 | Polyuria (HP:0000103) | 1.78392708 |
| 163 | Vaginal atresia (HP:0000148) | 1.77789545 |
| 164 | Astigmatism (HP:0000483) | 1.77373754 |
| 165 | Brushfield spots (HP:0001088) | 1.77127895 |
| 166 | Turricephaly (HP:0000262) | 1.77064138 |
| 167 | Increased CSF lactate (HP:0002490) | 1.76971254 |
| 168 | Abnormal protein glycosylation (HP:0012346) | 1.76447292 |
| 169 | Abnormal glycosylation (HP:0012345) | 1.76447292 |
| 170 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.76447292 |
| 171 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.76447292 |
| 172 | Hypolipoproteinemia (HP:0010981) | 1.76322866 |
| 173 | Congenital primary aphakia (HP:0007707) | 1.75686536 |
| 174 | Hepatocellular necrosis (HP:0001404) | 1.75418222 |
| 175 | Absent/shortened dynein arms (HP:0200106) | 1.75365870 |
| 176 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75365870 |
| 177 | Abnormality of the ileum (HP:0001549) | 1.75122729 |
| 178 | Rectal prolapse (HP:0002035) | 1.75061187 |
| 179 | Muscle fiber splitting (HP:0003555) | 1.74308108 |
| 180 | Progressive macrocephaly (HP:0004481) | 1.74129893 |
| 181 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73393117 |
| 182 | Fair hair (HP:0002286) | 1.72480867 |
| 183 | IgG deficiency (HP:0004315) | 1.71441683 |
| 184 | Proximal amyotrophy (HP:0007126) | 1.71304890 |
| 185 | Cortical dysplasia (HP:0002539) | 1.68501216 |
| 186 | Fasciculations (HP:0002380) | 1.68089269 |
| 187 | Polyphagia (HP:0002591) | 1.65288789 |
| 188 | Hepatic necrosis (HP:0002605) | 1.65199113 |
| 189 | Type 1 muscle fiber predominance (HP:0003803) | 1.65179048 |
| 190 | Hepatosplenomegaly (HP:0001433) | 1.65110940 |
| 191 | Follicular hyperkeratosis (HP:0007502) | 1.64336284 |
| 192 | Abnormality of purine metabolism (HP:0004352) | 1.64120497 |
| 193 | Vomiting (HP:0002013) | 1.63245636 |
| 194 | Fibular hypoplasia (HP:0003038) | 1.61150523 |
| 195 | Gonadotropin excess (HP:0000837) | 1.59303385 |
| 196 | Muscle stiffness (HP:0003552) | 1.58875750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 7.47370809 |
| 2 | CAMK1G | 5.11939317 |
| 3 | SIK1 | 4.47003046 |
| 4 | TRIB3 | 4.44944479 |
| 5 | BCKDK | 4.32706949 |
| 6 | NUAK1 | 3.21548754 |
| 7 | PDK4 | 3.14358988 |
| 8 | PDK3 | 3.14358988 |
| 9 | MAP4K2 | 2.89464914 |
| 10 | ADRBK2 | 2.62055023 |
| 11 | LMTK2 | 2.45589519 |
| 12 | MST1R | 2.41149237 |
| 13 | PDK2 | 2.29409886 |
| 14 | CASK | 2.24898509 |
| 15 | RIPK1 | 2.23289272 |
| 16 | GRK1 | 2.22864628 |
| 17 | ACVR1B | 2.21348776 |
| 18 | BMPR1B | 2.08595971 |
| 19 | PRKAA2 | 2.07695106 |
| 20 | ERN1 | 2.06208392 |
| 21 | TRIM28 | 1.97733431 |
| 22 | MAPK13 | 1.86538178 |
| 23 | OXSR1 | 1.85638961 |
| 24 | ZAK | 1.81720169 |
| 25 | MST4 | 1.76766429 |
| 26 | TAOK3 | 1.76678706 |
| 27 | WNK3 | 1.72506861 |
| 28 | INSRR | 1.65707907 |
| 29 | STK39 | 1.61223121 |
| 30 | FGFR3 | 1.58221638 |
| 31 | CDK9 | 1.48555315 |
| 32 | VRK2 | 1.48436088 |
| 33 | BCR | 1.48153783 |
| 34 | CDK6 | 1.43604714 |
| 35 | IRAK3 | 1.39458935 |
| 36 | TLK1 | 1.38203989 |
| 37 | MAP3K6 | 1.36686997 |
| 38 | WNK4 | 1.34462307 |
| 39 | TGFBR2 | 1.30042854 |
| 40 | MAP3K4 | 1.24908883 |
| 41 | FRK | 1.24311150 |
| 42 | MET | 1.20783749 |
| 43 | MARK1 | 1.18829076 |
| 44 | DDR2 | 1.18282258 |
| 45 | PDGFRA | 1.14667642 |
| 46 | TAF1 | 1.09638921 |
| 47 | VRK1 | 1.09433836 |
| 48 | PLK2 | 1.09063416 |
| 49 | CSNK1A1L | 1.07529522 |
| 50 | TIE1 | 1.06919128 |
| 51 | ADRBK1 | 1.06727287 |
| 52 | EPHB2 | 1.06507931 |
| 53 | TXK | 1.05572083 |
| 54 | EIF2AK3 | 1.05392758 |
| 55 | PRKAA1 | 1.05207298 |
| 56 | TEC | 1.05099117 |
| 57 | LATS1 | 1.04729851 |
| 58 | FGFR2 | 1.03202079 |
| 59 | PLK4 | 1.02248695 |
| 60 | CSNK1G2 | 0.98044605 |
| 61 | LATS2 | 0.97965793 |
| 62 | EIF2AK2 | 0.96648959 |
| 63 | PINK1 | 0.96026821 |
| 64 | CDK12 | 0.94392446 |
| 65 | MKNK2 | 0.93861749 |
| 66 | PIK3CA | 0.93385326 |
| 67 | PAK3 | 0.93318137 |
| 68 | JAK1 | 0.93300251 |
| 69 | PRKCE | 0.92746235 |
| 70 | CSNK1G1 | 0.91825320 |
| 71 | NEK9 | 0.91508109 |
| 72 | MYLK | 0.90341599 |
| 73 | DYRK2 | 0.89799490 |
| 74 | MAP2K7 | 0.89187066 |
| 75 | NTRK3 | 0.87657677 |
| 76 | CDK4 | 0.85771202 |
| 77 | PRKD3 | 0.85301161 |
| 78 | MAP2K1 | 0.83974861 |
| 79 | MARK3 | 0.83505063 |
| 80 | MAPK11 | 0.82490092 |
| 81 | TNIK | 0.82487004 |
| 82 | OBSCN | 0.81896973 |
| 83 | ERBB3 | 0.80238064 |
| 84 | EPHA4 | 0.79515179 |
| 85 | NEK6 | 0.79128460 |
| 86 | CSNK1G3 | 0.78957564 |
| 87 | JAK2 | 0.77584827 |
| 88 | MAP3K12 | 0.75878693 |
| 89 | IRAK1 | 0.71768257 |
| 90 | MTOR | 0.70228972 |
| 91 | STK38L | 0.69637853 |
| 92 | PRKACG | 0.68208049 |
| 93 | JAK3 | 0.68162786 |
| 94 | NME1 | 0.67145607 |
| 95 | GSK3A | 0.66758541 |
| 96 | TGFBR1 | 0.66089365 |
| 97 | FGFR4 | 0.65981456 |
| 98 | WEE1 | 0.65570197 |
| 99 | IGF1R | 0.63597173 |
| 100 | BMX | 0.62788359 |
| 101 | FLT3 | 0.62162786 |
| 102 | MAPKAPK3 | 0.61194950 |
| 103 | PHKG1 | 0.60346001 |
| 104 | PHKG2 | 0.60346001 |
| 105 | PDPK1 | 0.59781137 |
| 106 | PRKCG | 0.58832457 |
| 107 | CSK | 0.58344922 |
| 108 | PKN1 | 0.56957872 |
| 109 | MUSK | 0.56890369 |
| 110 | KIT | 0.56702473 |
| 111 | PRKCQ | 0.55431419 |
| 112 | CSF1R | 0.54650714 |
| 113 | PLK3 | 0.53069418 |
| 114 | SGK2 | 0.52455493 |
| 115 | STK16 | 0.52111181 |
| 116 | MAPKAPK5 | 0.51991611 |
| 117 | ICK | 0.51915406 |
| 118 | CAMK1 | 0.51377693 |
| 119 | CSNK1A1 | 0.51213110 |
| 120 | AKT3 | 0.50727409 |
| 121 | PRKG2 | 0.49847702 |
| 122 | BRSK2 | 0.49497153 |
| 123 | PDK1 | 0.49221523 |
| 124 | PRKCH | 0.49040504 |
| 125 | FER | 0.48828484 |
| 126 | STK3 | 0.47307087 |
| 127 | IKBKB | 0.46285785 |
| 128 | CCNB1 | 0.45823271 |
| 129 | INSR | 0.45630907 |
| 130 | CAMK2A | 0.45225447 |
| 131 | CAMKK2 | 0.44070839 |
| 132 | ABL2 | 0.43093217 |
| 133 | PRKCI | 0.42319532 |
| 134 | PRKD2 | 0.41480084 |
| 135 | ITK | 0.40834120 |
| 136 | ATM | 0.40173725 |
| 137 | PDGFRB | 0.39907786 |
| 138 | DYRK3 | 0.38585485 |
| 139 | CSNK1D | 0.36991867 |
| 140 | TYK2 | 0.36976231 |
| 141 | MAPK15 | 0.36712318 |
| 142 | CDK3 | 0.36563267 |
| 143 | RPS6KB1 | 0.36023973 |
| 144 | TNK2 | 0.36013635 |
| 145 | PTK2B | 0.35928597 |
| 146 | STK11 | 0.35856948 |
| 147 | ILK | 0.35786522 |
| 148 | FGFR1 | 0.34798086 |
| 149 | PAK2 | 0.33115723 |
| 150 | AKT1 | 0.32627417 |
| 151 | MAPK12 | 0.31231647 |
| 152 | GRK5 | 0.31217219 |
| 153 | TRPM7 | 0.30574236 |
| 154 | PKN2 | 0.29023583 |
| 155 | MAP2K3 | 0.28986833 |
| 156 | PRKD1 | 0.28893891 |
| 157 | ABL1 | 0.24817426 |
| 158 | MAPK7 | 0.24601346 |
| 159 | SRC | 0.22726178 |
| 160 | MAPK3 | 0.22442126 |
| 161 | TTN | 0.18746801 |
| 162 | EPHA2 | 0.17270953 |
| 163 | AKT2 | 0.17121485 |
| 164 | TTK | 0.17088980 |
| 165 | TYRO3 | 0.15957047 |
| 166 | MAP3K14 | 0.15167261 |
| 167 | DAPK2 | 0.15108762 |
| 168 | ERBB4 | 0.14815329 |
| 169 | MAPK1 | 0.12063498 |
| 170 | RET | 0.11704220 |
| 171 | MAP2K4 | 0.11692881 |
| 172 | CDK7 | 0.11489206 |
| 173 | MAPK4 | 0.11200842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.36348461 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.74844752 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.45659898 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.78987359 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.71612235 |
| 6 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.65665776 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.55469830 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.13479197 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.99676477 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.93380344 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.79349424 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.44003078 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 2.41865569 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.41146116 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.24021935 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03494273 |
| 17 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.01138437 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.98642750 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.96959993 |
| 20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.94784622 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88271281 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.86057300 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.84849522 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.83201825 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78229421 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.77645654 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75641446 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.74920590 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73657105 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.71956715 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67709814 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.65781597 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.65289050 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.60531388 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56845313 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49818025 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.48157432 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47770085 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44960661 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44392370 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43195143 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41596044 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32195239 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29332237 |
| 45 | GABAergic synapse_Homo sapiens_hsa04727 | 1.27299844 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.24766132 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22729739 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22181167 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 1.21604706 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20763389 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19015670 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.17544102 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 1.16497710 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.15968193 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15186510 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13827808 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13333317 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12627286 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.12297516 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11450966 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 1.09905305 |
| 62 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04197231 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96089228 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.93561637 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92780037 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89991690 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89783774 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86951164 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85827800 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85825467 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83670182 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82853705 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82415793 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80632371 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80550512 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78585930 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76772342 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73882971 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72777505 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70663626 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70558181 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70319443 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70018971 |
| 84 | Insulin secretion_Homo sapiens_hsa04911 | 0.69265524 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68341626 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67979756 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67517224 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67201177 |
| 89 | * Salivary secretion_Homo sapiens_hsa04970 | 0.66696379 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66419598 |
| 91 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66188431 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65845948 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.64014207 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63594129 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.63230238 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61329545 |
| 97 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60330018 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60041852 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59658333 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59277315 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58106264 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.56684958 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.55865284 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54728342 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53313402 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53195777 |
| 107 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52846631 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52215861 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51926596 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46713591 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45681972 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45434965 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45085026 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44470496 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44380114 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41567522 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39266920 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38810168 |
| 119 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38765232 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38147168 |
| 121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35831305 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35707865 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34723584 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33342806 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33331340 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32218868 |
| 127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30541098 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30174263 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27904078 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26768393 |
| 131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25183330 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.20963113 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20572556 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19322524 |
| 135 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18006497 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.16329151 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.15188591 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.15172255 |
| 139 | Legionellosis_Homo sapiens_hsa05134 | 0.13928736 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13752100 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.13667208 |
| 142 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.12984885 |
| 143 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.11952541 |
| 144 | Adherens junction_Homo sapiens_hsa04520 | 0.09283061 |
| 145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.09106018 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.08474364 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | 0.07997455 |
| 148 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.07988861 |
| 149 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06595378 |
| 150 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.05018900 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04774091 |
| 152 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.04769065 |
| 153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.04432927 |
| 154 | Malaria_Homo sapiens_hsa05144 | 0.04410620 |
| 155 | Pertussis_Homo sapiens_hsa05133 | 0.04205339 |
| 156 | Sulfur relay system_Homo sapiens_hsa04122 | 0.02960659 |
| 157 | Viral myocarditis_Homo sapiens_hsa05416 | 0.02894051 |
| 158 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.02799832 |
| 159 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.02041274 |
| 160 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.01844162 |
| 161 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.01029532 |
| 162 | Melanoma_Homo sapiens_hsa05218 | -0.0043753 |
| 163 | Sulfur metabolism_Homo sapiens_hsa00920 | -0.0040531 |

